VERV
Price
$5.50
Change
-$0.03 (-0.54%)
Updated
Jan 13 closing price
Capitalization
465.65M
43 days until earnings call
XRTX
Price
$1.25
Change
-$0.01 (-0.79%)
Updated
Jan 13 closing price
Capitalization
4.05M
Ad is loading...

VERV vs XRTX

Header iconVERV vs XRTX Comparison
Open Charts VERV vs XRTXBanner chart's image
Verve Therapeutics
Price$5.50
Change-$0.03 (-0.54%)
Volume$1.01M
Capitalization465.65M
XORTX Therapeutics
Price$1.25
Change-$0.01 (-0.79%)
Volume$42.15K
Capitalization4.05M
VERV vs XRTX Comparison Chart
Loading...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VERV vs. XRTX commentary
Jan 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VERV is a StrongBuy and XRTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 14, 2025
Stock price -- (VERV: $5.50 vs. XRTX: $1.25)
Brand notoriety: VERV and XRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VERV: 61% vs. XRTX: 161%
Market capitalization -- VERV: $465.65M vs. XRTX: $4.05M
VERV [@Biotechnology] is valued at $465.65M. XRTX’s [@Biotechnology] market capitalization is $4.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.53B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VERV’s FA Score shows that 0 FA rating(s) are green whileXRTX’s FA Score has 0 green FA rating(s).

  • VERV’s FA Score: 0 green, 5 red.
  • XRTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VERV is a better buy in the long-term than XRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VERV’s TA Score shows that 5 TA indicator(s) are bullish while XRTX’s TA Score has 4 bullish TA indicator(s).

  • VERV’s TA Score: 5 bullish, 2 bearish.
  • XRTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, VERV is a better buy in the short-term than XRTX.

Price Growth

VERV (@Biotechnology) experienced а -14.20% price change this week, while XRTX (@Biotechnology) price change was -4.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.85%. For the same industry, the average monthly price growth was -0.15%, and the average quarterly price growth was -4.30%.

Reported Earning Dates

VERV is expected to report earnings on May 07, 2025.

XRTX is expected to report earnings on May 01, 2024.

Industries' Descriptions

@Biotechnology (-5.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($466M) has a higher market cap than XRTX($4.05M). XRTX YTD gains are higher at: 10.659 vs. VERV (-2.482). XRTX has higher annual earnings (EBITDA): -4.33M vs. VERV (-219.97M). VERV has more cash in the bank: 540M vs. XRTX (2.3M). XRTX has less debt than VERV: XRTX (61.5K) vs VERV (71.3M). VERV has higher revenues than XRTX: VERV (24.4M) vs XRTX (0).
VERVXRTXVERV / XRTX
Capitalization466M4.05M11,515%
EBITDA-219.97M-4.33M5,086%
Gain YTD-2.48210.659-23%
P/E RatioN/A10.42-
Revenue24.4M0-
Total Cash540M2.3M23,468%
Total Debt71.3M61.5K115,935%
FUNDAMENTALS RATINGS
XRTX: Fundamental Ratings
XRTX
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
52
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
VERVXRTX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
87%
Momentum
ODDS (%)
Bullish Trend 7 days ago
88%
Bullish Trend 7 days ago
88%
MACD
ODDS (%)
Bullish Trend 7 days ago
83%
N/A
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 7 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
88%
Bullish Trend 7 days ago
88%
Advances
ODDS (%)
Bullish Trend 8 days ago
87%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 7 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 7 days ago
90%
View a ticker or compare two or three
Ad is loading...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NRINX21.590.05
+0.23%
Neuberger Berman Intrinsic Value R6
GILLX22.27N/A
N/A
Goldman Sachs Enh Core EqFund-Instl
KMDVX29.15N/A
N/A
Keeley Mid Cap Dividend Value A
HLCTX11.03N/A
N/A
Harding Loevner Intl Carb Trans Eq Inst
PRGTX20.53-0.22
-1.06%
T. Rowe Price Global Technology

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
-0.54%
BEAM - VERV
54%
Loosely correlated
-3.22%
CRSP - VERV
52%
Loosely correlated
-2.12%
NTLA - VERV
49%
Loosely correlated
-1.47%
PRME - VERV
49%
Loosely correlated
-5.78%
EDIT - VERV
48%
Loosely correlated
-7.94%
More

XRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRTX has been loosely correlated with VERV. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if XRTX jumps, then VERV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRTX
1D Price
Change %
XRTX100%
-0.79%
VERV - XRTX
43%
Loosely correlated
-0.54%
BCDA - XRTX
37%
Loosely correlated
+5.81%
SPHDF - XRTX
32%
Poorly correlated
N/A
TRML - XRTX
31%
Poorly correlated
-1.17%
BYSI - XRTX
26%
Poorly correlated
-1.20%
More